Artificial intelligence model accurately predicts novel drug compound response in humans

Artificial intelligence - Medication - AI

The length of time needed from a drug’s creation to its FDA approval is an exceptionally long one. A new application for artificial intelligence in the development of therapeutic compounds has the potential to one day help to reduce the amount of time needed for a new drug to receive its approval from the Food and Drug Administration. The current path takes more than a decade and can cost close to a billion dollars. A CUNY Graduate Center research team has developed an artificial intelligence (AI) model that may substantially…

Read More